Buy PE-22-28 10mg
59.99€
Buy PE-22-28 10mg
Researched Benefits:
- Selective TREK-1 potassium channel antagonist for investigating antidepressant-like signaling pathways
- Facilitates analysis of hippocampal brain-derived neurotrophic factor expression and activation
- Supports research on glutamatergic neurotransmission modulation and synaptic plasticity in assays
- Enables evaluation of rapid-acting neurogenic responses within controlled cellular assay models
Description
Buy PE-22-28 10mg
PE-22-28 10mg is a potent, short-chain research peptide (7 amino acids) derived from the spadin sequence and recognized for its high-affinity inhibition of the TREK-1 potassium channel. Manufactured from premium raw materials with state-of-the-art synthesis techniques, our PE-22-28 offers exceptional purity and stability, supporting rigorous neurological and psychiatric research applications.
Key Features:
-
≥95 % purity verified through rigorous HPLC analysis
-
Consistent batch-to-batch quality under cGMP-aligned production standards
-
Supplied lyophilized to ensure long-term stability when stored at −20 °C
Applications:
-
Investigating rapid-onset antidepressant mechanisms and mood stabilization
-
Exploring hippocampal neurogenesis and synaptic plasticity pathways
-
Studying neuroprotection and recovery following ischemic stroke or traumatic brain injury
-
Evaluating TREK-1 channel modulation in neurodegenerative disease models
Specifications and Documentation
-
Material Safety Data Sheet (MSDS): Coming Soon.
-
Handling and Storage Instructions: Coming Soon.
PE-22-28 10 mg stands out in pre-clinical neuroscience for its capacity to induce rapid neurochemical and behavioral adaptations, making it an invaluable tool for researchers probing novel therapeutic avenues in mental health and neuroprotection.
Buy PE-22-28 10mg
Reviews
There are no reviews yet.